175 related articles for article (PubMed ID: 33871760)
1. Is accurate routine cancer prognostication psychologically harmful? 5-year outcomes of life expectancy prognostication in uveal melanoma survivors.
Brown SL; Fisher P; Hope-Stone L; Damato B; Heimann H; Hussain R; Cherry MG
J Cancer Surviv; 2022 Apr; 16(2):408-420. PubMed ID: 33871760
[TBL] [Abstract][Full Text] [Related]
2. 'I Don't Like Uncertainty, I Like to Know': How and why uveal melanoma patients consent to life expectancy prognostication.
Brown SL; Fisher PL; Morgan A; Davies C; Olabi Y; Hope-Stone L; Heimann H; Hussain R; Cherry MG
Health Expect; 2022 Aug; 25(4):1498-1507. PubMed ID: 35474381
[TBL] [Abstract][Full Text] [Related]
3. Predictors of anxiety and depression 2 years following treatment in uveal melanoma survivors.
Brown SL; Hope-Stone L; Heimann H; Damato B; Salmon P
Psychooncology; 2018 Jul; 27(7):1727-1734. PubMed ID: 29601654
[TBL] [Abstract][Full Text] [Related]
4. Predictors of long-term anxiety and depression in uveal melanoma survivors: A cross-lagged five-year analysis.
Brown SL; Fisher PL; Hope-Stone L; Hussain RN; Heimann H; Damato B; Cherry MG
Psychooncology; 2020 Nov; 29(11):1864-1873. PubMed ID: 32779313
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial impact of prognostic genetic testing in uveal melanoma patients: a controlled prospective clinical observational study.
Lieb M; Tagay S; Breidenstein A; Hepp T; Le Guin CHD; Scheel J; Lohmann DR; Bornfeld N; Teufel M; Erim Y
BMC Psychol; 2020 Jan; 8(1):8. PubMed ID: 32005293
[TBL] [Abstract][Full Text] [Related]
6. Depression, Anxiety, and Regret Before and After Testing to Estimate Uveal Melanoma Prognosis.
Schuermeyer I; Maican A; Sharp R; Bena J; Triozzi PL; Singh AD
JAMA Ophthalmol; 2016 Jan; 134(1):51-6. PubMed ID: 26539659
[TBL] [Abstract][Full Text] [Related]
7. How do patients with uveal melanoma experience and manage uncertainty? A qualitative study.
Hope-Stone L; Brown SL; Heimann H; Damato B; Salmon P
Psychooncology; 2015 Nov; 24(11):1485-91. PubMed ID: 25873360
[TBL] [Abstract][Full Text] [Related]
8. Seven-year distress trajectories in uveal melanoma survivors.
Brown SL; Hope-Stone L; Cherry MG
Health Psychol; 2023 Apr; 42(4):247-256. PubMed ID: 36848060
[TBL] [Abstract][Full Text] [Related]
9. Prediction of all-cause mortality from 24 month trajectories in patient-reported psychological, clinical and quality of life outcomes in uveal melanoma patients.
Brown SL; Fisher PL; Hope-Stone L; Heimann H; Hussain R; Cherry MG
J Behav Med; 2022 Feb; 45(1):115-123. PubMed ID: 34453274
[TBL] [Abstract][Full Text] [Related]
10. Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients.
Gollrad J; Korpusik N; Rabsahl C; Boehmer D; Besserer A; Grittner U; Boeker A; Keilholz U; Joussen A; Budach V; Goerling U
Support Care Cancer; 2022 Jul; 30(7):5837-5847. PubMed ID: 35355121
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial impact of prognostic genetic testing in the care of uveal melanoma patients: protocol of a controlled prospective clinical observational study.
Erim Y; Scheel J; Breidenstein A; Metz CH; Lohmann D; Friederich HC; Tagay S
BMC Cancer; 2016 Jul; 16():408. PubMed ID: 27386847
[TBL] [Abstract][Full Text] [Related]
12. Depression in Uveal Melanoma Survivorship: Examining Psychological Predictors of Adjustment in the First Year Following Diagnosis.
Hoch MM; MacDonald JJ; Jorge-Miller A; McCannel TA; Beran TM; Stanton AL
Ann Behav Med; 2023 Nov; 57(12):1081-1096. PubMed ID: 37874742
[TBL] [Abstract][Full Text] [Related]
13. Genetic prognostication in uveal melanoma.
Dogrusöz M; Jager MJ
Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
[TBL] [Abstract][Full Text] [Related]
14. Associations between empirically proportionate and disproportionate fears of cancer recurrence and anxiety and depression in uveal melanoma survivors: Five-year prospective study.
Brown SL; Hope-Stone L; van der Voort N; Hussain R; Heimann H; Coventry WL; Cherry MG
Br J Health Psychol; 2024 Mar; ():. PubMed ID: 38462481
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study.
Rogiers A; Leys C; De Cremer J; Awada G; Schembri A; Theuns P; De Ridder M; Neyns B
Support Care Cancer; 2020 Jul; 28(7):3267-3278. PubMed ID: 31745697
[TBL] [Abstract][Full Text] [Related]
16. Two-year patient-reported outcomes following treatment of uveal melanoma.
Hope-Stone L; Brown SL; Heimann H; Damato B; Salmon P
Eye (Lond); 2016 Dec; 30(12):1598-1605. PubMed ID: 27589051
[TBL] [Abstract][Full Text] [Related]
17. Psychological variables associated with quality of life following primary treatment for head and neck cancer: a systematic review of the literature from 2004 to 2015.
Dunne S; Mooney O; Coffey L; Sharp L; Desmond D; Timon C; O'Sullivan E; Gallagher P
Psychooncology; 2017 Feb; 26(2):149-160. PubMed ID: 26918648
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.
Rogiers A; Leys C; Lauwyck J; Schembri A; Awada G; Schwarze JK; De Cremer J; Theuns P; Maruff P; De Ridder M; Bernheim JL; Neyns B
J Immunol Res; 2020; 2020():2192480. PubMed ID: 32775464
[TBL] [Abstract][Full Text] [Related]
19. Worry in Thyroid Cancer Survivors with a Favorable Prognosis.
Papaleontiou M; Reyes-Gastelum D; Gay BL; Ward KC; Hamilton AS; Hawley ST; Haymart MR
Thyroid; 2019 Aug; 29(8):1080-1088. PubMed ID: 31232194
[No Abstract] [Full Text] [Related]
20. Long-term uveal melanoma survivors: measuring their quality of life.
Frenkel S; Rosenne H; Briscoe D; Hendler K; Bereket R; Molcho M; Pe'er J
Acta Ophthalmol; 2018 Jun; 96(4):e421-e426. PubMed ID: 29369538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
